Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
Badge or pin
System and method for storing redundant information
Radiation imaging device
Audio conversation apparatus
Health monitoring of applications in a guest partition
RPM Controlled Wind Power Generation System
Food safety printer
  Randomly Featured Patents
Method of supporting the management of a communications network, and network management facility therefor
Method and device for production of lyophilized hydrochloride-1.beta., 10.beta.-epoxy-13-dimethylamino-guaia-3(4)-en-6,12-olide
Pattern matching vocoder using LSP parameters
Seat belt adjuster
Computer mainframe with superposed architecture
Folding combination chair seat and carrying case
Method for controlling engine start in a vehicle
External modular fixator for immobilization of a fracture
Automobile tire tread
Toy having remote control device and remote controlled model vehicle